WIC
HBIO icon

Woodmont Investment Counsel’s Harvard Bioscience HBIO Stock Holding History

Woodmont Investment Counsel’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,132
Closed -$195K – 183
2018
Q4 		$195K Hold
6,132
– – 0.05% 173
2018
Q3 		$322K Sell
6,132
-3,360
-35% -$189K 0.09% 136
2018
Q2 		$508K Sell
9,492
-1,770
-16% -$90.7K 0.14% 119
2018
Q1 		$563K Sell
11,262
-6,347
-36% -$285K 0.16% 118
2017
Q4 		$581K Sell
17,609
-140
-0.8% -$4.73K 0.15% 121
2017
Q3 		$666K Sell
17,749
-11,620
-40% -$344K 0.18% 115
2017
Q2 		$749K Sell
29,369
-1,711
-6% -$42.3K 0.21% 105
2017
Q1 		$808K Sell
31,080
-1,338
-4% -$38.5K 0.23% 106
2016
Q4 		$989K Buy
32,418
+6,166
+23% +$157K 0.28% 94
2016
Q3 		$714K Buy
26,252
+8,376
+47% +$233K 0.2% 116
2016
Q2 		$511K Sell
17,876
-5,145
-22% -$164K 0.15% 133
2016
Q1 		$695K Sell
23,021
-12,581
-35% -$357K 0.21% 109
2015
Q4 		$1.24M Buy
35,602
+15,905
+81% +$544K 0.36% 79
2015
Q3 		$745K Buy
19,697
+3,524
+22% +$164K 0.23% 107
2015
Q2 		$922K Sell
16,173
-4,844
-23% -$276K 0.27% 96
2015
Q1 		$1.22M Sell
21,017
-7,972
-28% -$428K 0.38% 77
2014
Q4 		$1.64M Sell
28,989
-1,170
-4% -$55.8K 0.5% 64
2014
Q3 		$1.23M Sell
30,159
-1,015
-3% -$46.7K 0.35% 87
2014
Q2 		$1.42M Buy
31,174
+10,761
+53% +$452K 0.4% 80
2014
Q1 		$968K Buy
20,413
+1,380
+7% +$62.8K 0.28% 108
2013
Q4 		$895K Buy
19,033
+6,788
+55% +$297K 0.27% 111
2013
Q3 		$488K Sell
12,245
-1,145
-9% -$45K 0.18% 126
2013
Q2 		$477K Buy
+13,390
New +$513K 0.16% 142

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Woodmont Investment Counsel's HBIO Position: Q1 2019 in Review

Woodmont Investment Counsel sold out of Harvard Bioscience (HBIO) in Q1 2019, closing a stake of 6,132 shares — an estimated $195K sold.

Woodmont Investment Counsel first reported a position in HBIO in Q2 2013 and held it in 23 quarters. The position peaked at $1.64M in Q4 2014. 87 funds tracked by Wall St. Rank hold HBIO as of Q1 2019.

  • Woodmont Investment Counsel reported no remaining Harvard Bioscience position as of Q1 2019 after selling out during the quarter.
  • Woodmont Investment Counsel sold 6,132 Harvard Bioscience shares in Q1 2019, an estimated $195K.
  • Woodmont Investment Counsel first reported a position in Harvard Bioscience in Q2 2013 and held it in 23 quarters.
  • Woodmont Investment Counsel's Harvard Bioscience position peaked at $1.64M in Q4 2014.
  • 87 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2019.

Based on Woodmont Investment Counsel's 13F filing for Q1 2019, filed 15 May 2019.